COMPAGNIE CHARGEURS INVEST (CRI.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:CRI • FR0000130692
10.24 EUR
-0.06 (-0.58%)
Last: Feb 2, 2026, 07:00 PM
Overall CRI gets a fundamental rating of 3 out of 10. We evaluated CRI against 16 industry peers in the Industrial Conglomerates industry. CRI may be in some trouble as it scores bad on both profitability and health. CRI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- CRI had positive earnings in the past year.
- CRI had a positive operating cash flow in the past year.
- Of the past 5 years CRI 4 years were profitable.
- In multiple years CRI reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.28%, CRI is doing worse than 68.75% of the companies in the same industry.
- CRI has a Return On Equity of 1.03%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- CRI has a Return On Invested Capital of 5.14%. This is in the better half of the industry: CRI outperforms 62.50% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for CRI is in line with the industry average of 6.41%.
- The 3 year average ROIC (4.65%) for CRI is below the current ROIC(5.14%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROIC | 5.14% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
1.3 Margins
- CRI has a Profit Margin of 0.37%. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- In the last couple of years the Profit Margin of CRI has declined.
- CRI has a Operating Margin (6.41%) which is in line with its industry peers.
- CRI's Operating Margin has been stable in the last couple of years.
- CRI has a Gross Margin of 28.51%. This is amonst the worse of the industry: CRI underperforms 81.25% of its industry peers.
- In the last couple of years the Gross Margin of CRI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% |
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRI is destroying value.
- Compared to 1 year ago, CRI has more shares outstanding
- The number of shares outstanding for CRI has been increased compared to 5 years ago.
- CRI has a better debt/assets ratio than last year.
2.2 Solvency
- CRI has an Altman-Z score of 1.24. This is a bad value and indicates that CRI is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.24, CRI is doing worse than 68.75% of the companies in the same industry.
- The Debt to FCF ratio of CRI is 124.09, which is on the high side as it means it would take CRI, 124.09 years of fcf income to pay off all of its debts.
- CRI has a Debt to FCF ratio of 124.09. This is in the lower half of the industry: CRI underperforms 68.75% of its industry peers.
- CRI has a Debt/Equity ratio of 1.38. This is a high value indicating a heavy dependency on external financing.
- Looking at the Debt to Equity ratio, with a value of 1.38, CRI is doing worse than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Altman-Z | 1.24 |
ROIC/WACC0.78
WACC6.58%
2.3 Liquidity
- A Current Ratio of 1.30 indicates that CRI should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.30, CRI is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
- CRI has a Quick Ratio of 1.30. This is a bad value and indicates that CRI is not financially healthy enough and could expect problems in meeting its short term obligations.
- CRI has a worse Quick ratio (0.86) than 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- CRI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.24%, which is quite impressive.
- The earnings per share for CRI have been decreasing by -14.59% on average. This is quite bad
- The Revenue has been growing slightly by 6.67% in the past year.
- Measured over the past years, CRI shows a small growth in Revenue. The Revenue has been growing by 3.10% on average per year.
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
3.2 Future
- CRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.19% yearly.
- The Revenue is expected to grow by 3.45% on average over the next years.
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 78.77, CRI can be considered very expensive at the moment.
- 68.75% of the companies in the same industry are cheaper than CRI, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 28.41. CRI is valued rather expensively when compared to this.
- A Price/Forward Earnings ratio of 13.43 indicates a correct valuation of CRI.
- 75.00% of the companies in the same industry are more expensive than CRI, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 25.64. CRI is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.77 | ||
| Fwd PE | 13.43 |
4.2 Price Multiples
- 75.00% of the companies in the same industry are more expensive than CRI, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, CRI is valued a bit more expensive than 62.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 74.96 | ||
| EV/EBITDA | 7.37 |
4.3 Compensation for Growth
- CRI's earnings are expected to grow with 32.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.4%
EPS Next 3Y32.19%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 1.27%, CRI has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 3.06, CRI is paying slightly less dividend.
- Compared to the average S&P500 Dividend Yield of 1.83, CRI is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CRI pays out 118.52% of its income as dividend. This is not a sustainable payout ratio.
DP118.52%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPA:CRI (2/2/2026, 7:00:00 PM)
10.24
-0.06 (-0.58%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)11-05 2025-11-05
Earnings (Next)02-11 2026-02-11/amc
Inst Owners4.68%
Inst Owner ChangeN/A
Ins Owners64.2%
Ins Owner ChangeN/A
Market Cap254.87M
Revenue(TTM)727.50M
Net Income(TTM)2.70M
Analysts74.29
Price Target11.56 (12.89%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.27% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP118.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-43.78%
EPS NY rev (3m)-58.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.77 | ||
| Fwd PE | 13.43 | ||
| P/S | 0.35 | ||
| P/FCF | 74.96 | ||
| P/OCF | 10.71 | ||
| P/B | 0.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.37 |
EPS(TTM)0.13
EY1.27%
EPS(NY)0.76
Fwd EY7.45%
FCF(TTM)0.14
FCFY1.33%
OCF(TTM)0.96
OCFY9.34%
SpS29.23
BVpS10.49
TBVpS-1.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.28% | ||
| ROE | 1.03% | ||
| ROCE | 7.02% | ||
| ROIC | 5.14% | ||
| ROICexc | 6.13% | ||
| ROICexgc | 13.12% | ||
| OM | 6.41% | ||
| PM (TTM) | 0.37% | ||
| GM | 28.51% | ||
| FCFM | 0.47% |
ROA(3y)1.05%
ROA(5y)2.21%
ROE(3y)3.33%
ROE(5y)7.74%
ROIC(3y)4.65%
ROIC(5y)5.48%
ROICexc(3y)5.7%
ROICexc(5y)7.48%
ROICexgc(3y)13.2%
ROICexgc(5y)17.03%
ROCE(3y)6.37%
ROCE(5y)7.53%
ROICexgc growth 3Y-6.3%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-7.54%
ROICexc growth 5Y-2.79%
OM growth 3Y1.32%
OM growth 5Y1.18%
PM growth 3Y-37.78%
PM growth 5Y-16.13%
GM growth 3Y3.87%
GM growth 5Y1.23%
F-Score7
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.38 | ||
| Debt/FCF | 124.09 | ||
| Debt/EBITDA | 4.67 | ||
| Cap/Depr | 66.89% | ||
| Cap/Sales | 2.8% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.87% | ||
| Profit Quality | 125.93% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.24 |
F-Score7
WACC6.58%
ROIC/WACC0.78
Cap/Depr(3y)59.11%
Cap/Depr(5y)54.94%
Cap/Sales(3y)2.51%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150.24%
EPS 3Y-38.62%
EPS 5Y-14.59%
EPS Q2Q%-146%
EPS Next Y-39.39%
EPS Next 2Y31.4%
EPS Next 3Y32.19%
EPS Next 5YN/A
Revenue 1Y (TTM)6.67%
Revenue growth 3Y-0.32%
Revenue growth 5Y3.1%
Sales Q2Q%-0.56%
Revenue Next Year2.38%
Revenue Next 2Y4.5%
Revenue Next 3Y3.45%
Revenue Next 5YN/A
EBIT growth 1Y57.43%
EBIT growth 3Y1%
EBIT growth 5Y4.32%
EBIT Next Year104.23%
EBIT Next 3Y38.23%
EBIT Next 5YN/A
FCF growth 1Y109.66%
FCF growth 3Y-17.92%
FCF growth 5Y170%
OCF growth 1Y244.24%
OCF growth 3Y-11.82%
OCF growth 5Y11.78%
COMPAGNIE CHARGEURS INVEST / CRI.PA FAQ
What is the ChartMill fundamental rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CRI.PA.
What is the valuation status of COMPAGNIE CHARGEURS INVEST (CRI.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to COMPAGNIE CHARGEURS INVEST (CRI.PA). This can be considered as Overvalued.
What is the profitability of CRI stock?
COMPAGNIE CHARGEURS INVEST (CRI.PA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for CRI stock?
The Price/Earnings (PE) ratio for COMPAGNIE CHARGEURS INVEST (CRI.PA) is 78.77 and the Price/Book (PB) ratio is 0.98.
How financially healthy is COMPAGNIE CHARGEURS INVEST?
The financial health rating of COMPAGNIE CHARGEURS INVEST (CRI.PA) is 1 / 10.